Localised rhabdomyosarcoma in infants (<12 months) and young children (12–36 months of age) treated on the EpSSG RMS 2005 study

Olga Slater,Jennifer E Gains,Anna M Kelsey,Federica De Corti,Ilaria Zanetti,Beatrice Coppadoro,Mette Jorgensen,Soledad Gallego,Daniel H Orbach,Heidi Glosli,Maja Cesen,Mark N Gaze,Naima Smeulders,Andrea Ferrari,Meriel Jenney,Veronique Minard-Colin,Gianni Bisogno,Johannes H M Merks

European Journal of Cancer（2022）

引用 8|浏览11

暂无评分

摘要

•Infants (<12 months) with localised RMS achieved improved outcome in this study.•This compares favourably with previous SIOP and European historical Studies.•Age under 12 months does not appear to be negative prognostic factor for survival.•Infants received radiotherapy particularly brachytherapy with increased frequency.

查看译文

关键词

Rhabdomyosarcoma,Infants,Young children,EpSSG,RMS 2005

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要